← Back to Gufic Biosciences Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

GUFICBIOPharmaceuticals

Gufic Biosciences Ltd — Financial Ratios & Key Metrics

₹273.80

-4.82%

P/E Ratio64.59xIndustry: 31.77x

ROE12.32%Return on equity

ROCE13.18%Return on capital

Debt/Equity0.59Low debt

💎

Valuation & Profitability

P/E Ratio

64.59x

Industry Average P/E

31.77x

Dividend Yield

0.03%

Market Cap

₹3.51K (Cr)

Sales Growth 5Y

16.69%

Profit Growth 5Y

25.23%

EPS Growth 5Y

19.04%

OPM 5Y Avg

18.21%

📉

Price Returns

1 Month

+7.62%

3 Months

-4.42%

6 Months

-5.49%

1 Year

-15.42%

52W Low

₹268

Current

₹274

52W High

₹408

4% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹297

▼ Price below SMA 50 — Bearish

SMA 200

₹341

▼ Long-term downtrend

Volume Signal

112% of avg

Average volume

Technical indicators are for educational purposes only. Not investment advice.

More on Gufic Biosciences Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.